Patents by Inventor Sebastian Hernandez
Sebastian Hernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20180202798Abstract: A visual positioning inspection cell for inspection of parts includes an inspection subsystem with sensors, and a positioning subsystem of the sensors with at least three cameras. Both systems are synchronized with each other by means of an indexing transmitted through a hardware line, for example accompanied by a timestamp. This allows more parts to be inspected or the position of more sensors to be detected. The visual positioning inspection method for inspection of parts associates the reading of each sensor with its position by an indexing between the positioning subsystem and the inspection subsystem including the sensors through the hardware line, interpolating, if necessary, the position of the sensors by means of a timestamp.Type: ApplicationFiled: December 15, 2017Publication date: July 19, 2018Inventor: Sebastián Hernández Serrano
-
Patent number: 5130445Abstract: There is disclosed a series of macrolides isolated from the fermentation broth of a microorganism identified as MA-5000 which morphological analysis reveals to be a strain of Streptomyces hygroscopicus. The compounds structures are presented based upon analytical studies. The compounds have antifungal activity.Type: GrantFiled: February 25, 1991Date of Patent: July 14, 1992Assignee: Merck & Co., Inc.Inventors: Richard W. Burg, Jerrold M. Liesch, Otto D. Hensens, Sebastian Hernandez
-
Patent number: 5028537Abstract: There is disclosed a series of macrolides isolated from the fermentation broth of a microorganism identified as MA-5000 which morphological analysis reveals to be a strain of Streptomyces hygroscopicus. The compounds' structures are present based upon analytical studies. The compounds have antifungal activity.Type: GrantFiled: June 6, 1988Date of Patent: July 2, 1991Assignee: Merck & Co. Inc.Inventors: Richard W. Burg, Otto D. Hensens, Jerrold M. Liesch, Sebastian Hernandez, Lucille J. Cole
-
Patent number: 4575500Abstract: There is disclosed a series of macrolides isolated from the fermentation broth of a microorganism identified as MA-5000 which morphological analysis reveals to be a strain of Streptomyces hygroscopicus. The compound's structure is presented based upon analytical studies. The compound has antifungal activity.Type: GrantFiled: March 26, 1984Date of Patent: March 11, 1986Assignee: Merck & Co., Inc.Inventors: Richard W. Burg, Lucille J. Cole, Sebastian Hernandez
-
Patent number: 4415669Abstract: There is disclosed a macrolide isolated from the fermentation broth of a microorganism identified as MA-5285 which morphological analysis reveals to be a strain of Streptomyces hygroscopicus. The compound's structure is presented based upon analytical studies. The compound has insecticidal and antiparasitic activity.Type: GrantFiled: December 7, 1981Date of Patent: November 15, 1983Assignee: Merck & Co., Inc.Inventor: Sebastian Hernandez
-
Patent number: 4385065Abstract: There is disclosed a novel series of compounds isolated from the fermentation broth of a strain of the microorganism Streptomyces sp MA5038. The compounds have a 16-membered macrocyclic lactone structure with various substituents thereon. The compounds have insecticidal and antitapeworm activity and compositions for such uses are disclosed.Type: GrantFiled: October 5, 1981Date of Patent: May 24, 1983Assignee: Merck & Co., Inc.Inventors: George E. Albers-Schonberg, Sebastian Hernandez, Leeyuan Huang
-
Patent number: 4311693Abstract: The antibiotic MSD A63A, having antibacterial and growth-permittant activity, is produced by fermentation of Streptoverticillum hiroshimense MA4845 (ATCC 31586), in a suitable nutrient media.Type: GrantFiled: November 17, 1980Date of Patent: January 19, 1982Assignee: Merck & Co., Inc.Inventors: Sebastian Hernandez, Sheldon B. Zimmerman, Vincent P. Gullo, Ray S. Dewey
-
Patent number: 4304867Abstract: The antibiotic thienamycin is active against both gram-positive and gram-negative bacteria. The antibiotic is produced by growing a newly-found and hitherto undescribed species of Streptomyces on suitable fermentation media.Type: GrantFiled: January 3, 1978Date of Patent: December 8, 1981Assignee: Merck & Co., Inc.Inventors: Jean S. Kahan, Frederick M. Kahan, Edward O. Stapley, Robert T. Goegelman, Sebastian Hernandez
-
Patent number: 4264736Abstract: The antibiotic MSD 890A.sub.10 and pharmaceutically acceptable salts thereof (hereinafter referred to as antibiotic 890A.sub.10) is active against both gram-positive and gram-negative bacteria. The antibiotic is produced by growing species of Streptomyces on suitable fermentation media.Type: GrantFiled: September 26, 1979Date of Patent: April 28, 1981Assignee: Merck & Co., Inc.Inventors: Patrick J. Cassidy, Sheldon B. Zimmerman, Josefino B. Tunac, Sebastian Hernandez
-
Patent number: 4264735Abstract: The antibiotic MSD 890A.sub.9 and pharmaceutically acceptable salts thereof (hereinafter referred to as antibiotic 890A.sub.9) is active against both gram-positive and gram-negative bacteria. The antibiotic is produced by growing species of Streptomyces on suitable fermentation media.Type: GrantFiled: September 10, 1979Date of Patent: April 28, 1981Assignee: Merck & Co., Inc.Inventors: Patrick J. Cassidy, Sheldon B. Zimmerman, Josefino B. Tunac, Sebastian Hernandez
-
Patent number: 4235967Abstract: The antibiotics MSD 890A.sub.1 and MSD 890A.sub.3 and pharmaceutically acceptable salts thereof (hereinafter referred to as antibiotics 890A.sub.1 and 890A.sub.3) are active against both gram-positive and gram-negative bacteria. The antibiotics are produced by growing species of Streptomyces on suitable fermentation media.Type: GrantFiled: April 6, 1979Date of Patent: November 25, 1980Assignee: Merck & Co., Inc.Inventors: Patrick J. Cassidy, Robert T. Goegelman, Edward O. Stapley, Sebastian Hernandez
-
Patent number: 4229534Abstract: The antibiotic N-acetyl thienamycin and its non-toxic pharmaceutically acceptable salts are active against both gram-positive and gram-negative bacteria. The antiobiotic is produced by growing a species of Streptomyces on suitable fermentation media or alternatively by acetylation of thienamycin.Type: GrantFiled: April 5, 1979Date of Patent: October 21, 1980Assignee: Merck & Co., Inc.Inventors: Jean S. Kahan, Frederick M. Kahan, Robert T. Goegelman, Edward O. Stapley, Sebastian Hernandez
-
Patent number: 4168202Abstract: The antibiotics MSD 890A.sub.2 and MSD 890A.sub.5 and pharmaceutically acceptable salts thereof (hereinafter referred to as antibiotics 890A.sub.2 and 890A.sub.5) are active against both gram-positive and gram-negative bacteria. The antibiotics are produced by growing species of Streptomyces on suitable fermentation media.Type: GrantFiled: July 8, 1977Date of Patent: September 18, 1979Assignee: Merck & Co., Inc.Inventors: Patrick J. Cassidy, Robert T. Goegelman, Edward O. Stapley, Sebastian Hernandez
-
Patent number: 4165379Abstract: The antibiotic N-acetyl thienamycin and its non-toxic pharmaceutically acceptable salts are active against both gram-positive and gram-negative bacteria. The antibiotic is produced by growing a species of Streptomyces on suitable fermentation media or alternatively by acetylation of thienamycin.Type: GrantFiled: August 25, 1977Date of Patent: August 21, 1979Assignee: Merck & Co., Inc.Inventors: Jean S. Kahan, Frederick M. Kahan, Robert T. Goegelman, Edward O. Stapley, Sebastian Hernandez
-
Patent number: 4162324Abstract: The antibiotics MSD 890A.sub.1 and MSD 890A.sub.3 and pharmaceutically acceptable salts thereof (hereinafter referred to as antibiotics 890A.sub.1 and 890A.sub.3) are active against both gram-positive and gram-negative bacteria. The antibiotics are produced by growing species of Streptomyces on suitable fermentation media.Type: GrantFiled: August 25, 1977Date of Patent: July 24, 1979Assignee: Merck & Co., Inc.Inventors: Patrick J. Cassidy, Robert T. Goegelman, Edward O. Stapley, Sebastian Hernandez
-
Patent number: 4141986Abstract: The antibiotics MSD 890A.sub.2 and MSD 890A.sub.5 and pharmaceutically acceptable salts thereof (hereinafter referred to as antibiotics 890A.sub.2 and 890A.sub.5) are active against both gram-positive and gram-negative bacteria. The antibiotics are produced by growing species of Streptomyces on suitable fermentation media.Type: GrantFiled: August 5, 1977Date of Patent: February 27, 1979Assignee: Merck & Co., Inc.Inventors: Patrick J. Cassidy, Robert T. Goegelman, Edward O. Stapley, Sebastian Hernandez
-
Patent number: 4081548Abstract: The antibiotic thienamycin is active against both gram-positive and gram-negative bacteria. The antibiotic is produced by growing a newly-found and hitherto undescribed species of Streptomyces on suitable fermentation media.Type: GrantFiled: September 3, 1976Date of Patent: March 28, 1978Assignee: Merck & Co., Inc.Inventors: Jean S. Kahan, Frederick M. Kahan, Edward O. Stapley, Robert T. Goegelman, Sebastian Hernandez
-
Patent number: 4007090Abstract: This invention relates to a novel process for the preparation of the antibiotic Sulfomycin. The antibiotic is obtained by the fermentation of a nutrient medium with a Sulfomycin producing strain of the previously unknown microorganism Streptomyces cineroviridis.Type: GrantFiled: April 2, 1976Date of Patent: February 8, 1977Assignee: Merck & Co., Inc.Inventors: Louis Chaiet, Sebastian Hernandez, Sheldon B. Zimmerman
-
Patent number: 4006060Abstract: The antibiotic thienamycin is active against both gram-positive and gram-negative bacteria. The antibiotic is produced by growing a newly-found and hitherto undescribed species of Streptomyces on suitable fermentation media.Type: GrantFiled: November 18, 1975Date of Patent: February 1, 1977Assignee: Merck & Co., Inc.Inventors: Jean S. Kahan, Frederick M. Kahan, Edward O. Stapley, Robert T. Goegelman, Sebastian Hernandez
-
Patent number: 3950357Abstract: The antibiotic thienamycin is active against both gram-positive and gram-negative bacteria. The antibiotic is produced by growing a newly-found and hitherto undescribed species of Streptomyces on suitable fermentation media.Type: GrantFiled: November 25, 1974Date of Patent: April 13, 1976Assignee: Merck & Co., Inc.Inventors: Jean S. Kahan, Frederick M. Kahan, Edward O. Stapley, Robert T. Goegelman, Sebastian Hernandez